Co-solvent solubilization of some poorly-soluble antidiabetic drugs
- 1 April 2009
- journal article
- research article
- Published by Informa UK Limited in Pharmaceutical Development and Technology
- Vol. 14 (2), 185-192
- https://doi.org/10.1080/10837450802498894
Abstract
Co-solvent solubilization approach has been used to enhance the solubility of seven antidiabetic drugs: gliclazide, glyburide, glipizide, glimepiride, repaglinide, pioglitazone, and roziglitazone. Solubility in water, phosphate buffer (pH 7.4), six co-solvent solutions prepared in water as well as phosphate buffer (pH 7.4) and pH-solubility profile of various drugs have been determined at 25°C. Aqueous solubility of various drugs was found to be less than 0.04 mg/mL. Solubility of gliclazide, glipizide and repaglinide increased by 3-6 times by using phosphate buffer (pH 7.4) as solvent. Solubility enhancement by pH modification was not sufficient. Significant enhancement in solubility could be achieved by the use of co-solvents. The combined effect of co-solvent and buffer was synergistic and enormous increase in solubility of sulfonylureas and repaglinide could be achieved. In the case of glitazones, however, co-solvent alone caused significant enhancement; the presence of buffer had negative effect on the solubilization potential of the co-solvents. Up to 763, 316, 153, 524, 297, 792 and 513 times increase in solubility could be achieved in the case of gliclazide, glyburide, glimepiride, glipizide, repaglinide, pioglitazone and rosiglitazone, respectively.Keywords
This publication has 16 references indexed in Scilit:
- Implication of inclusion complexation of glimepiride in cyclodextrin–polymer systems on its dissolution, stability and therapeutic efficacyInternational Journal of Pharmaceutics, 2006
- Ionization, lipophilicity and solubility properties of repaglinideJournal of Pharmaceutical and Biomedical Analysis, 2006
- Characterization of solid dispersions of rofecoxib using differential scanning calorimeterJournal of Thermal Analysis and Calorimetry, 2005
- Solubilizing Excipients in Oral and Injectable FormulationsPharmaceutical Research, 2004
- In Vitro and In Vivo Evaluation of Glibenclamide in Solid Dispersion SystemsDrug Development and Industrial Pharmacy, 2004
- Physicochemical properties of the binary system glibenclamide and polyethylene glycol 4000Journal of Thermal Analysis and Calorimetry, 2004
- Physicochemical characterization and dissolution properties of nimesulide-cyclodextrin binary systemsAAPS PharmSciTech, 2003
- Solubilization by cosolventsInternational Journal of Pharmaceutics, 2002
- Study of the inclusion of gliclazide in α-cyclodextrinJournal of Pharmaceutical and Biomedical Analysis, 1998
- Development of a dissolution medium for glibenclamideInternational Journal of Pharmaceutics, 1996